Q8 is a potent anti-angiogenic agent and a CysLT1 antagonist (IC50 = 4.9 μM); it reduces intracellular levels of NF-κB and calpain-2, as well as the secretion of pro-angiogenic proteins such as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and vascular endothelial growth factor (VEGF).